Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patients on Chronic Ventilation- a Pilot Study

NCT02208700 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2014-08-05

No results posted yet for this study

Summary

Patients with mechanical ventilation have shown improved weaning rates when enteral tube feeding high in EPA, GLA and antioxidants were fed to patients in the critical care setting.

LTAC Patients on chronic mechanical ventilation will have decreased days an mechanical ventilation, decreased mortality rates and decreased organ failure when fed an enteral product high in EPA, GLA and antioxidants compared to an isotonic high fiber enteral nutrition product.

Conditions

  • Acute Lung Injury
  • Mechanical Ventilation Complication
  • Dietary Modification

Interventions

OTHER

Oxepa

Therapeutic nutrition with EPA, GLA\< and antioxidants

OTHER

Jevity 1.5

Complete balanced nutrition with a unique fiber blend

Sponsors & Collaborators

  • Abbott Nutrition

    collaborator INDUSTRY
  • Grace Hospital, Cleveland, Ohio

    lead OTHER

Principal Investigators

  • Basma Ricaurte, MD · Grace Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02208700 on ClinicalTrials.gov